Javier Borja

454 total citations
22 papers, 279 citations indexed

About

Javier Borja is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Javier Borja has authored 22 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Physiology. Recurrent topics in Javier Borja's work include Atrial Fibrillation Management and Outcomes (4 papers), Asthma and respiratory diseases (4 papers) and Respiratory and Cough-Related Research (3 papers). Javier Borja is often cited by papers focused on Atrial Fibrillation Management and Outcomes (4 papers), Asthma and respiratory diseases (4 papers) and Respiratory and Cough-Related Research (3 papers). Javier Borja collaborates with scholars based in Spain, United States and Philippines. Javier Borja's co-authors include Iñaki Izquierdo, Alberto Herrejón, Marc Miravitlles, Eva Baró, Catherine Bisbal, Ioana Agache, Feo F, Jorge Máspero, B. Sánchez and E Martí-Guadaño and has published in prestigious journals such as European Heart Journal, Allergy and Clinical Therapeutics.

In The Last Decade

Javier Borja

21 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Borja Spain 10 134 95 89 29 26 22 279
Dragoș Bumbăcea Romania 8 248 1.9× 236 2.5× 47 0.5× 16 0.6× 31 1.2× 22 351
Özlem Keskin Türkiye 11 146 1.1× 121 1.3× 55 0.6× 8 0.3× 34 1.3× 34 325
Leyla Pur Özyiğit Türkiye 6 98 0.7× 50 0.5× 42 0.5× 37 1.3× 24 0.9× 34 235
Samantha Seymour United States 9 147 1.1× 157 1.7× 11 0.1× 24 0.8× 59 2.3× 18 343
Masuo Nakamura Japan 12 58 0.4× 82 0.9× 11 0.1× 12 0.4× 85 3.3× 28 337
CK Lai China 7 382 2.9× 238 2.5× 196 2.2× 8 0.3× 32 1.2× 8 503
Vincent Gros France 14 721 5.4× 640 6.7× 238 2.7× 28 1.0× 41 1.6× 40 849
Kiyoshi Sekiya Japan 15 499 3.7× 314 3.3× 255 2.9× 81 2.8× 71 2.7× 70 756
R J Stead United Kingdom 14 62 0.5× 361 3.8× 23 0.3× 12 0.4× 95 3.7× 21 524
Alfredo Cocci Italy 6 31 0.2× 18 0.2× 30 0.3× 54 1.9× 16 0.6× 9 356

Countries citing papers authored by Javier Borja

Since Specialization
Citations

This map shows the geographic impact of Javier Borja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Borja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Borja more than expected).

Fields of papers citing papers by Javier Borja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Borja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Borja. The network helps show where Javier Borja may publish in the future.

Co-authorship network of co-authors of Javier Borja

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Borja. A scholar is included among the top collaborators of Javier Borja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Borja. Javier Borja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borja, Javier, et al.. (2024). Molecular Docking and Pharmacokinetic Profiling of Nab-paclitaxel as Advanced Chemotherapeutic Agent Against HER-2 Positive Breast Cancer Patients. Asian Pacific Journal of Cancer Prevention. 25(10). 3447–3456. 1 indexed citations
2.
Miravitlles, Marc, et al.. (2011). COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respiratory Medicine. 105(5). 740–747. 33 indexed citations
3.
Antonijoan, Rosa, Ignasi Gich, Analía Azaro, et al.. (2011). Gastrointestinal safety of triflusal solution in healthy volunteers: a proof of concept endoscopic study. European Journal of Clinical Pharmacology. 67(7). 663–669. 2 indexed citations
4.
5.
Valero, Antonio, Fernando De la Torre, José A. García del Castillo, et al.. (2009). Safety of Rupatadine Administered Over a Period of 1 Year in the Treatment of Persistent Allergic Rhinitis. Drug Safety. 32(1). 33–42. 23 indexed citations
6.
7.
Fraj, J., et al.. (2007). Safety of triflusal (antiplatelet drug) in patients with aspirin‐exacerbated respiratory diseases. Allergy. 63(1). 112–115. 9 indexed citations
8.
Martínez‐Cócera, C., E Martí-Guadaño, Jordi Jiménez Conde, et al.. (2005). Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.. PubMed. 15(1). 22–9. 37 indexed citations
9.
Borja, Javier, et al.. (2003). Reacciones adversas a medicamentos en pacientes ancianos hospitalizados. Medicina Clínica. 121(10). 398c–399.
10.
Borja, Javier. (2002). Role of low–molecular-weight heparin in the management of acute coronary syndromes. Current Opinion in Cardiology. 17(6). 608–612. 4 indexed citations
11.
F, Feo, et al.. (2001). Tachyphylaxis following regular use of formoterol in exercise-induced bronchospasm.. PubMed. 11(3). 176–82. 37 indexed citations
12.
13.
Barberán, José, et al.. (1999). Oral ofloxacin versus parenteral imipenem-cilastatin in the treatment of osteomyelitis.. PubMed. 12(3). 244–9. 21 indexed citations
14.
Gimeno, Concepción, et al.. (1998). In vitro Interaction between Ofloxacin and Cefotaxime against Gram-Positive and Gram-Negative Bacteria Involved in Serious Infections. Chemotherapy. 44(2). 94–98. 14 indexed citations
15.
Galindo, P. A., et al.. (1998). Fixed drug eruption caused by cyproterone acetate. Allergy. 53(8). 813–813. 1 indexed citations
16.
Ramos‐Barbón, David, et al.. (1996). Ofloxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbation of chronic bronchitis. Clinical Therapeutics. 18(3). 440–447. 6 indexed citations
17.
Borja, Javier, et al.. (1993). Evaluation of the methodological quality of clinical trial protocols. European Journal of Clinical Pharmacology. 44(4). 401–402. 5 indexed citations
18.
Borja, Javier, et al.. (1992). Aromatase Inhibitors: Clinical Pharmacology and Therapeutic Implications in Breast Cancer. Journal of International Medical Research. 20(4). 303–312. 13 indexed citations
19.
Luna, Antoni Bayés de, et al.. (1990). Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the cast study. Cardiovascular Drugs and Therapy. 4(3). 651–655. 3 indexed citations
20.
Obach, R., Javier Borja, Josep María Vallès, et al.. (1988). Lack of Correlation Between Lithium Pharmacokinetic Parameters Obtained from Plasma and Saliva. Therapeutic Drug Monitoring. 10(3). 265–268. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dragoș Bumbăcea Breakdown of academic impact, for papers by Özlem Keskin Breakdown of academic impact, for papers by Leyla Pur Özyiğit Breakdown of academic impact, for papers by Samantha Seymour Breakdown of academic impact, for papers by Masuo Nakamura Breakdown of academic impact, for papers by CK Lai Breakdown of academic impact, for papers by Vincent Gros Breakdown of academic impact, for papers by Kiyoshi Sekiya Breakdown of academic impact, for papers by R J Stead Breakdown of academic impact, for papers by Alfredo Cocci
Rankless by CCL
2026